Related Experiment Video
Updated: Jul 7, 2025

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
Unsymmetrical Pd(II) Pincer Complexes with Benzothiazole and Thiocarbamate Flanking Units: Expedient Solvent-Free
Vladimir A Kozlov1, Diana V Aleksanyan1,2, Svetlana G Churusova1
1A. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, ul. Vavilova 28, Str. 1, 119334 Moscow, Russia.
Abstract:
Driven by the growing threat of cancer, many research efforts are directed at developing new chemotherapeutic agents, where the central role is played by transition metal complexes. The proper ligand design serves as a key factor to unlock the anticancer potential of a particular metal center. Following a recent trend, we have prepared unsymmetrical pincer ligands that combine benzothiazole and thiocarbamate donor groups. These compounds are shown to readily undergo direct cyclopalladation, affording the target S,C,N-type Pd(II) pincer complexes both in solution and in the absence of a solvent. The solid-phase strategy provided the complexes in an efficient and ecologically friendly manner. The resulting palladacycles are fully characterized using nuclear magnetic resonance (NMR) and infrared (IR) spectroscopy and, in one case, by single-crystal X-ray diffraction (XRD). The solvent-free reactions are additionally analyzed by powder XRD. The pincer complexes exhibit remarkable cytotoxicity against several solid and blood cancer cell lines, including human colorectal carcinoma (HCT116), breast cancer (MCF7), prostate adenocarcinoma (PC3), chronic myelogenous leukemia (K562), multiple plasmacytoma (AMO1), and acute lymphoblastic leukemia (H9), with the dimethylamino-substituted derivative being particularly effective. The latter also induced an appreciable level of apoptosis in both parental and doxorubicin-resistant cells K562 and K562/iS9, vindicating the high anticancer potential of this type of palladacycles.
Insights
New palladium(II) pincer complexes show potent anticancer activity against diverse cancer cell lines. These novel compounds, synthesized using an efficient solid-phase strategy, offer promising therapeutic potential for cancer treatment.
Area of Science:
- Medicinal Chemistry
- Organometallic Chemistry
- Cancer Research
Background:
- Cancer remains a significant global health threat, driving the search for novel chemotherapeutic agents.
- Transition metal complexes are central to developing new anticancer drugs.
- Ligand design is crucial for optimizing the anticancer efficacy of metal complexes.
Purpose of the Study:
- To synthesize novel unsymmetrical pincer ligands combining benzothiazole and thiocarbamate donor groups.
- To prepare S,C,N-type Pd(II) pincer complexes via direct cyclopalladation.
- To evaluate the anticancer cytotoxicity and apoptosis-inducing potential of the synthesized palladacycles.
Main Methods:
- Synthesis of unsymmetrical pincer ligands.
- Direct cyclopalladation for Pd(II) complex formation (solution and solvent-free).
- Characterization using NMR, IR, and X-ray diffraction (single-crystal and powder).
- Cytotoxicity assays against multiple solid and blood cancer cell lines.
- Apoptosis induction studies in drug-sensitive and drug-resistant leukemia cells.
Main Results:
- Efficient synthesis of S,C,N-type Pd(II) pincer complexes was achieved using a solid-phase strategy.
- The synthesized palladacycles demonstrated significant cytotoxicity against human colorectal carcinoma (HCT116), breast cancer (MCF7), prostate adenocarcinoma (PC3), chronic myelogenous leukemia (K562), multiple plasmacytoma (AMO1), and acute lymphoblastic leukemia (H9) cell lines.
- A dimethylamino-substituted derivative showed particularly high efficacy and induced apoptosis in both parental and doxorubicin-resistant K562 cells.
Conclusions:
- Unsymmetrical pincer ligands enable the efficient synthesis of novel Pd(II) complexes with potent anticancer properties.
- The developed palladacycles exhibit broad-spectrum cytotoxicity and overcome drug resistance, highlighting their therapeutic potential.
- This research validates the anticancer promise of S,C,N-type palladacycles for future drug development.
More Related Videos
Related Concept Videos
Diazonium Group Substitution with Halogens and Cyanide: Sandmeyer and Schiemann Reactions
Electrophilic Aromatic Substitution: Fluorination and Iodination of Benzene
Nucleophilic Aromatic Substitution: Elimination–Addition

